Pyrotinib Plus Trastuzumab and Chemotherapy in HER2+ Metastatic Breast Cancer Patients
Clinical trial NCT05839288 · COMPLETED
Trial details
- NCT number
- NCT05839288
- Sponsor
- Fudan University
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-11-01
- Primary completion
- 2023-03-01
- Enrollment
- 161
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.